Abstract:New Delhi metallo-beta-lactmase-1 (NDM-1) has recently emerged as a global threat because of its ability to confer resistance to almost all clinically used beta-lactam antibiotics, its presence within an easily transmissible plasmid bearing a number of other antibiotic resistance determinants, its carriage in a variety of enterobacteria, and its presence in both nosocomial and community-acquired infections. To improve our understanding of the molecular basis of this threat, NDM-1 was purified and characterized. Recombinant NDM-1 bearing its native leader sequence was expressed in Escherichia coli BL21 cells. The major processed form found to be released into culture media contains a 35-residue truncation at the N-terminus. This form of NDM-1 is monomeric and can be purified with 1.8 or 1.0 equiv of zinc ion, depending on the experimental conditions. Treatment of dizinc NDM-1 with EDTA results in complete removal of both zinc ions, but the relatively weaker chelator PAR chelates only 1 equiv of zinc ion from folded protein but 1.9 equiv of zinc ion from denatured protein, indicating different affinities for each metal binding site. UV-vis spectroscopy of the dicobalt metalloform along with molecular dynamics simulations of the dizinc metallo form indicates that the dinuclear metal cluster at the active site of NDM-1 is similar in structure to other class B1 metallo-beta-lactamases. Supplementation of excess zinc ions to monozinc NDM-1 has differential effects on enzyme activity with respect to three different classes of beta-lactam substrates tested, penems, cephems, and carbapenems, and likely reflects dissimilar contributions of the second equivalent of metal ion to the catalysis of the hydrolysis of these substrates. Fits to these concentration dependencies are used to approximate the K-d value of the more weakly bound zinc ion (2 mu M). NDM-1 achieved maximal activity with all substrates tested when supplemented with approximately 10 mu M ZnSO4, displaying k(cat)/K-M values ranging from 1.4 x 10(6) to 2.0 x 10(7) M-1 s(-1), and a slight preference for cephem substrates. This work provides a foundation for an improved understanding of the molecular basis of NDM-1-mediated antibiotic resistance and should allow more quantitative studies to develop targeted therapeutics.

A Novel New Delhi Metallo-β-Lactamase Variant, NDM-14, Isolated in a Chinese Hospital Possesses Increased Enzymatic Activity Against Carbapenems

A novel New Delhi metallo-β-lactamase variant NDM-14 isolated from a Chinese

Emergence of NDM-producing Non- Baumannii Acinetobacter Spp. Isolated from China

Emergence of Novel Variants of Β-Lactamase Gene Blaadc and Outer Membrane Porin Gene Caro in Drug-Resistant Acinetobacter Baumannii

NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings

High Incidence and Endemic Spread of NDM-1-Positive Enterobacteriaceae in Henan Province, China

Draft Genome Sequence of a Multidrug-Resistant New Delhi Metallo-Β-lactamase NDM-1-producing Acinetobacter Pittii Sequence Type 207 Isolate from China.

Novel Variant of New Delhi Metallo-β-lactamase, NDM-20, in Escherichia Coli.

Dissemination of bla NDM-5 gene via an IncX3-type plasmid among non-clonal Escherichia coli in China

Identification of New Delhi Metallo-Β-lactamase Gene (NDM-1) from a Clinical Isolate of Acinetobacter Junii in China.

New Delhi Metallo-β-Lactamase (NDM-1): an Updates

Plasmid-Mediated Novel Blandm-17 Gene Encoding a Carbapenemase with Enhanced Activity in a Sequence Type 48 Escherichia Coli Strain.

New Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China

Bla(ndm-21), a New Variant of Bla(ndm) in an Escherichia Coli Clinical Isolate Carrying Bla(ctx-M-55) and Rmtb

Distribution and molecular epidemiology of New Delhi metallo-β-lactamase variants in carbapenem-resistant Enterobacteriaceae

Deciphering the Role of V88L Substitution in NDM-24 Metallo-β-Lactamase

Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health

Recent research and development of NDM-1 inhibitors

Resistance mechanism and molecular epidemiology of the New Delhi metallo-β-lactamase-1 possessing Klebsiella pneumoniae

Detection of New Delhi Metallo-Beta-Lactamase (encoded by Blandm-1 ) in Enterobacter Aerogenes in China.

Characterization of purified New Delhi metallo-β-lactamase-1